The success of GLP-1 medications for treating Type 2 diabetes and obesity naturally leads to a related question: Do GLP-1 drugs affect cancer risk, which is often associated with obesity and Type...
Read More >
The U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal cancer, following encouraging results from a clinical trial led in part...
Read More >
For more than 35 years, University of Oklahoma Health Campus researchers have played a key role in the Strong Heart Study, a landmark project that has uncovered critical insights into...
Read More >
Abdul Rafeh Naqash, M.D., associate professor at the University of Oklahoma College of Medicine and an oncologist at OU Health Stephenson Cancer Center, has been named a fellow of the American...
Read More >
OKLAHOMA CITY – More than 800 people attended the 2025 Connect+Cure Gala on Wednesday night, raising $4.7 million to support research and programs at the University of Oklahoma Health Harold...
Read More >
Citing a background of innovative cancer research, the Indian National Science Academy (INSA) has elected OU’s Priyabrata Mukherjee, Ph.D., as a foreign fellow. His fellowship will...
Read More >